Skip to main content
. 2016 Aug 19;95(33):e4512. doi: 10.1097/MD.0000000000004512

Figure 3.

Figure 3

AMH levels at diagnosis and at final follow-up of young female patients after treatment for Wilms tumor (WT) without whole abdominal radiotherapy or stem cell transplantation (WT1), osteosarcoma (OS), Ewing sarcoma (ES), and WT including whole abdominal radiotherapy or stem cell transplantation (WT2). Time from diagnosis to final follow-up after completion of treatment was a mean of 1.5, 3.7, 3.9, and 3.9 years for the 4 groups, respectively. The arrowhead represents a value outside the diagram, 8.2. The gray lines depict the median AMH levels of each group. AMH = anti-Müllerian hormone.